stockrow
Friday 6 November 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024.
- Revenue
- −13.0%
- EPS
- +67.9%
- Free cash flow
- +22.0%
Quarter to September 2026, against a year earlier
11.94
0.17
−1.40%
Follow AMWL
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 6 | 6 |
+8 more TTM periods Free account |
| (23.18%) | (29.54%) | (32.20%) | (33.93%) | ||
| (17.08%) | (21.82%) | (23.58%) | (25.19%) | ||
ROIC |
(91.47%) | (135.53%) | (95.94%) | (100.51%) | |
Return on Tangible Assets |
(34.24%) | (45.00%) | (50.09%) | (55.10%) | |
Average Days of Receivables |
94.15 | 87.87 | 87.79 | 72.75 | |
Free Cash Flow per Share |
(1.64) | (1.91) | (2.69) | (4.11) | |
Free Cash Flow |
(27.92) | (32.04) | (44.63) | (65.97) | |
Capital Expenditures |
(8.63) | (5.65) | (2.80) | (0.02) | |
| Other line items | |||||
Cash ROIC |
(6.86%) | (7.43%) | (10.62%) | (15.34%) | |
Accounts Receivable Turnover |
3.84 | 4.12 | 3.68 | 4.10 | |
Accounts Payable Turnover |
20.68 | 38.77 | 28.59 | 34.95 | |
Inventory Turnover |
74.78 | 66.81 | 60.80 | 57.59 | |
Average Days of Payables |
13.84 | 5.89 | 4.53 | 5.17 | |
Days of Inventory on Hand |
3.20 | 3.35 | 3.75 | 3.72 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
21.90% | 25.28% | 26.60% | 29.22% | |
Selling, General and Administrative Expense of Revenue |
46.88% | 48.99% | 50.97% | 52.67% | |
Share Based Compensation of Revenue |
5.33% | 5.95% | 7.15% | 8.83% | |
Operating CF/Net income |
0.34 | 0.34 | 0.48 | 0.69 | |
Depreciation/Fixed assets |
209.63 | 217.48 | 209.24 | 167.12 | |
Capex/Depreciation |
(0.27) | (0.16) | (0.08) | 0.00 | |
Revenue per Share |
12.38 | 13.04 | 14.31 | 15.54 | |
Operating CF per Share |
(1.13) | (1.57) | (2.52) | (4.11) | |
Capex per Share |
(0.51) | (0.34) | (0.17) | 0.00 | |
Capex to Sales |
0.04 | 0.03 | 0.01 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026